Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 3, 2008, Pages 962-970

  Isaacs, Charles E ^a   Wen, Guang Y ^a   Xu, Weimin ^a   Jun, Hua Jia ^a   Rohan, Lisa ^b   Corbo, Christopher ^a   Di Maggio, Vincenzo ^a   Jenkins Jr , Edmund C ^a   Hillier, Sharon ^c  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; EPIGALLOCATECHIN GALLATE; GLYCOPROTEIN B; GLYCOPROTEIN D;

ANALYTIC METHOD; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; IMMUNOGOLD ELECTRON MICROSCOPY; MOLECULAR WEIGHT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; VIRION; VIRUS ATTACHMENT; VIRUS ENVELOPE; VIRUS ISOLATION; VIRUS TRANSMISSION;

ANIMALS; CATECHIN; CELL LINE; CERCOPITHECUS AETHIOPS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; MICROSCOPY, ELECTRON; VERO CELLS; VIRION; VIRUS INACTIVATION;

EID: 40549091363     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00825-07     Document Type: Article

References (55)

1. Aurelian, L. 2004. Minireview. Herpes simplex virus type 2 vaccines: new ground for optimism? Clin. Diagn. Lab. Immunol. 11:437-445.
2. Barton, S. 2005. The role of anti-HSV therapeutics in the HIV-infected host and in controlling the HIV epidemic. Herpes 12:15-22.
3. Cai, Y., N. D. Anavy, and H.-H. S. Chow. 2002. Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats. Drug Metab. Dispos. 30:1246-1249.
4. Campadelli-Fiume, G., M. Amasio, E. Avitabile, A. Cerretani, C. Forghieri, T. Gianni, and L. Menotti. 2007. The multipartite system that mediates entry of herpes simplex virus into the cell. Rev. Med. Virol. 17:313-326.
5. Chen, L., M.-J. Lee, H. Li, and C. S. Yang. 1997. Absorption distribution and elimination of tea polyphenols in rats. Drug Metab. Dispos. 25:1045-1050.
6. Cheshenko, N., M. J. Keller, V. MasCasullo, G. A. Jarvis, H. Cheng, M. John, J.-H. Li, K. Hogarty, R. A. Anderson, D. P. Waller, L. J. D. Zaneveld, A. T. Profy, M. E. Klotman, and B. C. Herold. 2004. Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread. Antimicrob. Agents Chemother. 48:2025-2036.
7. Chow, H.-H. S., I. A. Hakim, D. R. Vining, J. A. Crowell, J. Ranger-Moore, W. M. Chew, C. A. Celaya, S. R. Rodney, Y. Hara, and D. S. Alberts, 2005. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals. Clin. Cancer Res. 11:4627-4633.
8. Chu, D.-C., and L. R. Juneja. 1997. General chemical composition of green tea and its infusion, p. 13-22. In T. Yamamoto, L. R. Juneja, D.-C. Chu, and M. Kim (ed.), Chemistry and applications of green tea. CRC Press, New York, NY.
9. Cohen, J. 2005. Prevention cocktails: combining tools to stop HIV's spread. Science 309:1002-1005.
10. Ermakova, S., B. Y. Choi, H. S. Choi, B. S. Kang, A. M. Bode, and Z. Dong. 2005. The intermediate filament protein vimentin is a new target for epigallocatechin gallate. J. Biol. Chem. 29:16882-16890.
11. Fang, M. Z., Y. Wang, N. Ai, Z. Hou, Y. Sun, H. Lu, W. Welsh, and C. S. Yang. 2003. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 67:7563-7570.
12. Farnsworth, A., T. W. Wisner, M. Webb, R. Roller, G. Cohen, R. Eisenberg, and D. C. Johnson. 2007. Herpes simplex virus glycoproteins gB and gH function in fusion between the virion envelope and the outer nuclear membrane. Proc. Natl. Acad. Sci. USA 204:10187-10192.
13. Fleming, D. G., G. M. McQuillan, R. E. Johnson, A. J. Nahmias, S. O. Aral, F. K. Lee, and M. E. St. Louis. 1997. Herpes simplex virus type 2 in the United States, 1976 to 1994. N. Engl. J. Med. 337:1105-1111.
14. Hamilton-Miller, J. M. T. 1995. Antimicrobial properties of tea (Camellia sinensis L.). Antimicrob. Agents Chemother. 39:2375-2377.
15. Hamza, A., and C.-G. Zhan. 2006. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors. J. Phys. Chem. B 110:2910-2917.
16. Heldwein, E. E., H. Lou, F. C. Bender, G. H. Cohen, R. J. Eisenberg, and S. C. Harrison. 2006. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 313:217-220.
17. Hillier, S., and K. K. Holmes. 1999. Bacterial vaginosis, p. 563-586. In K. K. Holmes, et al. (ed.), Sexually transmitted diseases, third edition. McGraw-Hill, New York, NY.
18. Jöbstl, E., J. R. Howse, J. P. A. Fairclough, and M. P. Williamson. 2006. Noncovalent cross-linking of casein by epigallocatechin gallate characterized by single molecule force microscopy. J. Agric. Food Chem. 54:4077-4081.
19. Kanaka, S., M. Kim, M. Taniguchi, and T. Yamamoto. 1989. Antibacterial substances in lapanese green tea extract against streptococcus mutans, a cariogenic bacterium. Agric. Biol. Chem. 53:2307-2311.
20. Kawai, K., N. H. Tsuno, J. Kitayama, Y. Okaji, K. Yazawa, M. Asakage, N. Hori, T. Watanabe, K. Takahashi, and H. Nagawa. 2003. Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding. J. Allergy Clin. Immunol. 112:951-957.
21. Koelle, D. M. 2006. Vaccines for herpes simplex virus infections. Curr. Opin. Investig. Drugs 7:136-141.
22. Kusuda, M., T. Hatano, and T. Yoshida. 2006. Water-soluble complexes formed by natural polyphenols and bovine serum albumin: evidence from gel electrophoresis. Biosci. Biotechnol. Biochem. 70:152-160.
23. Lambert, J. D., D. H. Kim, R. Zheng, and C. S. Yang. 2006. Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice. J. Pharm. Pharmacol. 58:599-604.
24. Li, C., A. Allen, J. Kwagh, N. M. Doliba, W. Qin, H. Najafi, H. W. Collins, F. M. Matschinsky, C. A. Stanley, and T. J. Smith. 2006. Green tea polyphenols modulate insulin secretion by inhibiting glutamate dehydrogenase. J. Biol. Chem. 281:10214-10221.
25. Manoj, S., C. R. Jogger, D. Myscofski, M. Yoon, and P. G. Spear. 2004. Mutations in herpes simplex virus glycoprotein D that prevent cell entry via nectins and alter cell tropism. Proc. Natl. Acad. Sci. USA 101:12414-12421.
26. Mindel, A. 1998. Genital herpes - how much of a public-health problem? Lancet 351:16-18.
27. Mukhtar, H., and N. Ahmad. 2000. Tea polyphenols: prevention of cancer and optimizing health. Am. J. Clin. Nutr. 71:1698S-1702S.
28. Nagot, N., A. Ouédraogo, V. Foulongne, I. Konaté, H. A. Weiss, L. Vergne, M.-C. Defer, Sanon A. Djagbaré, J.-B. Andonaba, P. Becquart, M. Segondy, R. Vallo, A. Sawadogo, P. Van de Perre, and P. Mayaud. 2007. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N. Engl. J. Med. 356:790-799.
29. Nakayama, M., K. Suzuki, M. Toda, S. Okubo, Y. Hara, and T. Shimamura. 1993. Inhibition of the infectivity of influenza virus by tea polyphenols. Antivir. Res. 21:289-299.
30. Nakayama, T., J. Shirane, K. Hieshima, M. Shibano, M. Watanabe, Z. Jin, D. Nagakubo, T. Saito, Y. Shimomura, and O. Yoshie. 2006. Novel antiviral activity of chemokines. Virology 350:484-492.
31. Nam, S., D. M. Smith, and Q. P. Dou. 2001. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J. Biol. Chem. 276:13322-13330.
32. Overington, J. P., B. Al-Lazikani, and A. L. Hopkins. 2006. How many drug targets are there? Nature 5:993-996.
33. Palermo, C. M., C. A. Westlake, and T. A. Gasiewicz. 2005. Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. Biochemistry 44:5041-5052.
34. Paterson, I., and E. A. Anderson. 2005. The renaissance of natural products as drug candidates. Science 310:451-453.
35. Quinn, T. C., M. J. Wawer, N. Sewankambo, D. Serwadda, C. Li, F. Wabwire-Mangen, M. O. Meehan, T. Lutalo, and R. H. Gray. 2000. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N. Engl. J. Med. 342:921-929.
36. Reed, L. J., and M. Muench. 1938. A simple method of estimating 50 per cent end points. Am. J. Hyg. 27:493-497.
37. Sah, J. F., S. Balasubramanian, R. L. Eckert, and E. A. Rorke. 2004. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. J. Biol. Chem. 279:12755-12762.
38. Sang, S., M.-J. Lee, C.-T. Ho, and C. S. Yang. 2005. Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions. J. Agric. Food Chem. 53:9478-9484.
39. Shimizu, M., A. Deguchi, J. T. E. Lim, H. Moriwaki, L. Kopelovich, and I. B. Weinstein. 2005. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin. Cancer Res. 11:2735-2746.
40. Song, J.-M., K.-H. Lee, and B.-L. Seong. 2005. Antiviral effect of catechins in green tea on influenza virus. Antivir. Res. 68:66-74.
41. Spurr, A. R. 1969. A low viscosity epoxy resin and embedding medium for electron microscopy. J. Ultrastruct. Res. 26:31-43.
42. Stanberry, L. R. 2004. Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines. Herpes 11:161A-169A.
43. Subramanian, R. P., and R. J. Geraghty. 2007. Herpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L, and B. Proc. Natl. Acad. Sci. USA 104:2903-2908.
44. Tachibana, H., K. Koga, Y. Fujimura, and K. Yamada. 2004. A receptor for green tea polyphenol EGCG. Nat. Struct. Mol. Biol. 4:380-381.
45. Thormar, H., C. E. Isaacs, H. R. Brown, M. R. Barshatzky, and T. Pessolano. 1987. Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides. Antimicrob. Agents Chemother. 31:27-31.
46. Trybala, E., J.-Å. Liljeqvist, B. Svennerholm, and T. Bergström. 2000. Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate. J. Virol. 74:9106-9114.
47. Vermund, S. H. 2004. Prevention of mother-to-child transmission of HIV in Africa. Top. HIV Med. 12:130-134.
48. Wald, A. 2004. Synergistic interactions between herpes simplex virus type-2 and human immunodeficiency virus epidemics. Herpes 11:70-76.
49. Wen, G. Y., S. Y. Yang, W. Kaczmarski, X. Y. He, and K. Pappas. 2002. Presence of hydroxysteroid dehydrogenase type 10 in Hsia's APP-Sw transgenic mouse brains, but absent in amyloid plaques of Alzheimer's disease brains. Brain Res. 954:115-122.
50. White, M. K., T. S. Gorrill, and K. Khalili. 2006. Reciprocal transactivation between HIV-1 and other human viruses. Virology 352:1-13.
51. Whitley, R. J. 1994. Herpes simplex virus infections of women and their offspring: implications for a developed society. Proc. Natl. Acad. Sci. USA 91:2441-2447.
52. Williamson, M. P., T. G. McCormick, C. L. Nance, and W. T. Shearer. 2006. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: potential for HIV-1 therapy. J. Allergy Clin. Immunol. 118:1369-1374.
53. Yasin, B., W. Wang, M. Pang, N. Cheshenko, T. Hong, A. J. Waring, B. C. Herold, E. A. Wagar, and R. I. Lehrer. 2004. θ defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J. Virol. 78:5147-5156.
54. Zhang, Y.-M., and C. O. Rock. 2004. Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase. J. Biol. Chem. 279:30994-31001.
55. Zhu, Q. Y., A. Zhang, D. Tsang, Y. Huang, and Z. Y. Chen. 1997. Stability of green tea catechins. J. Agric. Food Chem. 45:4624-4628.